Skip to main content

Advertisement

Log in

PFAPA syndrome and Behçet’s disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists

  • Brief Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The pediatric syndrome characterized by periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) and adult Behçet’s disease share some clinical manifestations and are both polygenic autoinflammatory disorders with interleukin-1β showing to play a pivotal role. However, the diagnosis is mostly clinical and we hypothesize that specific criteria may be addressed differently by different physicians. To determine the diagnostic variability, we compared the answers of 80 patients with a definite diagnosis of Behçet’s disease (age 42.1 ± 13.7 years) obtained by separate telephone interviews conducted by a rheumatologist, a pediatrician, and an internist working largely in the field of autoinflammatory disorders. Questions were related to the age of symptom onset, the occurrence of recurrent fevers during childhood, and the association with oral aphthosis, cervical adenitis and/or pharyngitis, previous treatments, possible growth impairment, the time lapse between PFAPA-like symptoms and the onset of Behçet’s disease, and the occurrence of Behçet-related manifestation during childhood. The rheumatologist identified 30 % of patients with Behçet’s disease fulfilling PFAPA syndrome diagnostic criteria, compared to the pediatrician and the internist identifying 10 and 7.5 %, respectively. Most of the patients suffered from recurrent oral aphthosis in childhood also without fever (50, 39, and 48 % with each interviewer), yet no patient fulfilled the Behçet’s disease diagnostic criteria. Our data suggest that physician awareness and expertise are central to the diagnosis of autoinflammatory disorders through an accurate collection of the medical history.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Marshall GS, Edwards KM, Butler J, Lawton AR (1987) Syndrome of periodic fever, pharyngitis, and aphthous stomatitis. J Pediatr 110:43–46

    Article  CAS  PubMed  Google Scholar 

  2. Rigante D (2012) The fresco of autoinflammatory diseases from the pediatric perspective. Autoimmun Rev 11:348–356

    Article  PubMed  Google Scholar 

  3. Stojanov S, Lapidus S, Chitkara P et al (2011) Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) is a disorder of innate immunity and Th1 activation responsive to IL-1 blockade. Proc Natl Acad Sci U S A 108:7148–7153

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Kolly L, Busso N, von Scheven-Gete A et al (2013) Periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis syndrome is linked to dysregulated monocyte IL-1β production. J Allergy Clin Immunol 131:1635–1643

    Article  CAS  PubMed  Google Scholar 

  5. Marshall GS, Edwards KM, Lawton AR (1989) PFAPA syndrome. Pediatr Infect Dis J 8:658–659

    Article  CAS  PubMed  Google Scholar 

  6. Thomas KT, Feder HM Jr, Lawton AR, Edwards KM (1999) Periodic fever syndrome in children. J Pediatr 135:15–21

    Article  CAS  PubMed  Google Scholar 

  7. Cantarini L, Vitale A, Bartolomei B, Galeazzi M, Rigante D (2012) Diagnosis of PFAPA syndrome applied to a cohort of 17 adults with unexplained recurrent fevers. Clin Exp Rheumatol 30:269–271

    PubMed  Google Scholar 

  8. Padeh S, Stoffman N, Berkun Y (2008) Periodic fever accompanied by aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA syndrome) in adults. Isr Med Assoc J 10:358–360

    PubMed  Google Scholar 

  9. Padeh S, Brezniak N, Zemer D et al (1999) Periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome: clinical characteristics and outcome. J Pediatr 135:98–101

    Article  CAS  PubMed  Google Scholar 

  10. Gül A (2005) Behçet's disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 4:81–83

    Article  PubMed  Google Scholar 

  11. Gül A, Tugal-Tutkun I, Dinarello CA et al (2012) Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behçet's disease: an open-label pilot study. Ann Rheum Dis 71:563–566

    Article  PubMed  Google Scholar 

  12. Cantarini L, Vitale A, Borri M, Galeazzi M, Franceschini R (2012) Successful use of canakinumab in a patient with resistant Behçet's disease. Clin Exp Rheumatol 30:S115

    CAS  PubMed  Google Scholar 

  13. Vitale A, Rigante D, Caso F et al (2014) Inhibition of interleukin-1 by canakinumab as a successful mono-drug strategy for the treatment of refractory Behçet's disease: a case series. Dermatology 228:211–214

    Article  PubMed  Google Scholar 

  14. Cantarini L, Vitale A, Scalini P, Dinarello CA, Rigante D, Franceschini R et al (2013) Anakinra treatment in drug-resistant Behçet's disease: a case series. Clin Rheumatol. doi:10.1007/s10067-013-2443-8

    PubMed  Google Scholar 

  15. Yosipovitch G, Shohat B, Bshara J, Wysenbeek A, Weinberger A (1995) Elevated serum interleukin 1 receptors and interleukin 1B in patients with Behçet's disease: correlations with disease activity and severity. Isr J Med Sci 31:345–348

    CAS  PubMed  Google Scholar 

  16. Zou J, Guan JL (2014) Interleukin-1-related genes polymorphisms in Turkish patients with Behçet disease: a meta-analysis. Mod Rheumatol 24:321–326

    Article  CAS  PubMed  Google Scholar 

  17. International Study Group for Behçet disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080

    Google Scholar 

  18. Zhou ZY, Chen SL, Shen N, Lu Y (2012) Cytokines and Behçet's disease. Autoimmun Rev 11:699–704

    Article  CAS  PubMed  Google Scholar 

  19. Pineton de Chambrun M, Wechsler B, Geri G et al (2012) New insights into the pathogenesis of Behcet's disease. Autoimmun Rev 11:687–698

    Article  CAS  PubMed  Google Scholar 

  20. Consolandi C, Turroni S, Emmi G et al (2014) Behçet's syndrome patients exhibit specific microbiome signature. Autoimun Rev. doi:10.1016/j.autrev.2014.11.009

    Google Scholar 

  21. Esposito S, Bianchini S, Fattizzo M et al (2014) The enigma of periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome. Pediatr Infect Dis J 33:650–652

    Article  PubMed  Google Scholar 

  22. Federici L, Rittore-Domingo C, Koné-Paut I et al (2006) A decision tree for genetic diagnosis of hereditary periodic fever in unselected patients. Ann Rheum Dis 65:1427–1432

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Cantarini L, Vitale A, Lucherini OM et al (2014) The labyrinth of autoinflammatory disorders: a snapshot on the activity of a third-level center in Italy. Clin Rheumatol. doi:10.1007/s10067-014-2721-0

    PubMed Central  Google Scholar 

  24. Davatchi F, Shahram F, Chams-Davatchi C et al (2010) Behçet’s disease in Iran: analysis of 6500 cases. Int J Rheum Dis 13:367–373

    Article  PubMed  Google Scholar 

  25. Hofer M, Pillet P, Cochard MM et al (2014) International periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis syndrome cohort: description of distinct phenotypes in 301 patients. Rheumatology (Oxford) 53:1125–1129

    Article  Google Scholar 

Download references

Conflict of interest

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Luca Cantarini.

Additional information

Luca Cantarini, Antonio Vitale, Carlo Selmi, and Donato Rigante equally contributed to the work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cantarini, L., Vitale, A., Bersani, G. et al. PFAPA syndrome and Behçet’s disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists. Clin Rheumatol 35, 501–505 (2016). https://doi.org/10.1007/s10067-015-2890-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-015-2890-5

Keywords

Navigation